Aditya Narain1,2, Chun Shing Kwok1,2, Mamas A Mamas1,2. 1. Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK. 2. University Hospital of North Midlands, Stoke-on-Trent, UK.
Abstract
BACKGROUND: It is unclear whether consumption of sugar- or artificially sweetened beverages is independently associated with the development of metabolic syndrome. A systematic review and meta-analysis was performed to evaluate whether soft drink consumption is associated with the development of metabolic syndrome. METHODS: Medline and EMBASE were searched in November 2015 for studies which considered soft drink (sugar-sweetened beverage [SSB] and artificially sweetened beverage [ASB]) intake and risk of metabolic syndrome. Pooled risk ratios for adverse outcomes were calculated using inverse variance with a random effects model, and heterogeneity was assessed using the I2 statistic. RESULTS: A total of 12 studies (eight cross-sectional, four prospective cohort studies) with 56 244 participants (age range 6-98 years) were included in the review. Our pooled analysis found that soft drink intake is associated with metabolic syndrome. This relationship is shown in cross-sectional studies of SSB consumption (RR 1.46, 95% CI 1.18-1.91) and both cross-sectional and prospective studies of ASB consumption (RR 2.45; 95% CI 1.15-5.14; RR 1.32, 95% CI 1.21-1.44, respectively). However, pooled results of prospective cohort studies of SSB consumption found no association between intake and risk of developing metabolic syndrome. CONCLUSIONS: Sugar-sweetened beverage and ASB intake are both associated with metabolic syndrome. This association may be driven by the fact that soft drink intake serves as a surrogate for an unhealthy lifestyle, or an adverse cardiovascular risk factor profile.
BACKGROUND: It is unclear whether consumption of sugar- or artificially sweetened beverages is independently associated with the development of metabolic syndrome. A systematic review and meta-analysis was performed to evaluate whether soft drink consumption is associated with the development of metabolic syndrome. METHODS: Medline and EMBASE were searched in November 2015 for studies which considered soft drink (sugar-sweetened beverage [SSB] and artificially sweetened beverage [ASB]) intake and risk of metabolic syndrome. Pooled risk ratios for adverse outcomes were calculated using inverse variance with a random effects model, and heterogeneity was assessed using the I2 statistic. RESULTS: A total of 12 studies (eight cross-sectional, four prospective cohort studies) with 56 244 participants (age range 6-98 years) were included in the review. Our pooled analysis found that soft drink intake is associated with metabolic syndrome. This relationship is shown in cross-sectional studies of SSB consumption (RR 1.46, 95% CI 1.18-1.91) and both cross-sectional and prospective studies of ASB consumption (RR 2.45; 95% CI 1.15-5.14; RR 1.32, 95% CI 1.21-1.44, respectively). However, pooled results of prospective cohort studies of SSB consumption found no association between intake and risk of developing metabolic syndrome. CONCLUSIONS:Sugar-sweetened beverage and ASB intake are both associated with metabolic syndrome. This association may be driven by the fact that soft drink intake serves as a surrogate for an unhealthy lifestyle, or an adverse cardiovascular risk factor profile.
Authors: May A Beydoun; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Greg A Dore; Jose A Canas; Michele K Evans; Alan B Zonderman Journal: Br J Nutr Date: 2018-03 Impact factor: 3.718
Authors: Zhila Semnani-Azad; Tauseef A Khan; Sonia Blanco Mejia; Russell J de Souza; Lawrence A Leiter; Cyril W C Kendall; Anthony J Hanley; John L Sievenpiper Journal: JAMA Netw Open Date: 2020-07-01
Authors: Rosângela Maria Lopes Sousa; Nathalee Liberal Xavier Ribeiro; Bruno Araújo Serra Pinto; Jonas Rodrigues Sanches; Mariana Uchôa da Silva; Caio Fernando Ferreira Coêlho; Lucas Martins França; José Albuquerque de Figueiredo Neto; Antonio Marcus de Andrade Paes Journal: Nutr Metab (Lond) Date: 2018-07-24 Impact factor: 4.169
Authors: Danielle E Haslam; Nicola M McKeown; Mark A Herman; Alice H Lichtenstein; Hassan S Dashti Journal: Front Endocrinol (Lausanne) Date: 2018-01-08 Impact factor: 5.555
Authors: Alice J Owen; Michael J Abramson; Jill F Ikin; Tracy A McCaffrey; Sylvia Pomeroy; Brigitte M Borg; Caroline X Gao; David Brown; Danny Liew Journal: Nutrients Date: 2020-03-23 Impact factor: 5.717